The mGluR5 antagonist AFQ056 does not affect methylation and transcription of the mutant <it>FMR1 </it>gene <it>in vitro</it>
<p>Abstract</p> <p>Background</p> <p>Fragile X syndrome (FXS), the leading cause of inherited mental retardation, is due to expansion and methylation of a CGG sequence in the <it>FMR1 </it>gene, which result in its silencing and consequent absence of FMRP pr...
Saved in:
Main Authors: | Tabolacci Elisabetta (Author), Pirozzi Filomena (Author), Gomez-Mancilla Baltazar (Author), Gasparini Fabrizio (Author), Neri Giovanni (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2012-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Progress toward therapeutic potential for AFQ056 in Fragile X syndrome
by: Sourial M, et al.
Published: (2013) -
Correlation of Receptor Occupancy of Metabotropic Glutamate Receptor Subtype 1 (mGluR1) in Mouse Brain With In vivo Activity of Allosteric mGluR1 Antagonists
by: Gentaroh Suzuki, et al.
Published: (2009) -
mGluR-dependent synaptic plasticity in drug-seeking.
by: Camilla eBellone, et al.
Published: (2012) -
Mechanism of neuroprotective effect of mGluR4 agonists
by: Natalya V. Avdeeva, et al.
Published: (2019) -
Translational concepts of mGluR5 in synaptic diseases of the brain
by: Thomas M Piers, et al.
Published: (2012)